A detailed history of Concourse Financial Group Securities, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 55 shares of REGN stock, worth $40,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Previous 46 19.57%
Holding current value
$40,590
Previous $48,000 18.75%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$1024.09 - $1201.76 $9,216 - $10,815
9 Added 19.57%
55 $57,000
Q2 2024

Jul 23, 2024

BUY
$883.2 - $1071.19 $5,299 - $6,427
6 Added 15.0%
46 $48,000
Q1 2024

Apr 30, 2024

BUY
$902.69 - $993.35 $10,832 - $11,920
12 Added 42.86%
40 $38,000
Q4 2023

Feb 07, 2024

BUY
$775.18 - $881.7 $5,426 - $6,171
7 Added 33.33%
28 $24,000
Q3 2023

Oct 25, 2023

SELL
$692.45 - $844.37 $692 - $844
-1 Reduced 4.55%
21 $17,000
Q2 2023

Aug 10, 2023

BUY
$700.03 - $830.35 $3,500 - $4,151
5 Added 29.41%
22 $15,000
Q4 2022

Jan 30, 2023

BUY
$705.89 - $766.39 $3,529 - $3,831
5 Added 41.67%
17 $0
Q3 2022

Nov 15, 2022

BUY
$573.97 - $724.32 $6,313 - $7,967
11 Added 1100.0%
12 $8,000
Q2 2022

Aug 09, 2022

SELL
$548.35 - $738.84 $2,741 - $3,694
-5 Reduced 83.33%
1 $1,000
Q1 2022

May 09, 2022

SELL
$595.12 - $698.43 $166,038 - $194,861
-279 Reduced 97.89%
6 $4,000
Q4 2021

Feb 07, 2022

BUY
$543.48 - $670.97 $1,630 - $2,012
3 Added 1.06%
285 $180,000
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $20,665 - $24,514
36 Added 14.63%
282 $171,000
Q2 2021

Aug 13, 2021

SELL
$472.8 - $558.54 $2,836 - $3,351
-6 Reduced 2.38%
246 $137,000
Q1 2021

May 13, 2021

BUY
$446.73 - $548.2 $75,050 - $92,097
168 Added 200.0%
252 $119,000
Q4 2020

Feb 02, 2021

SELL
$478.3 - $607.98 $59,309 - $75,389
-124 Reduced 59.62%
84 $41,000
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $80,078 - $96,756
147 Added 240.98%
208 $116,000
Q2 2020

Aug 13, 2020

BUY
$493.32 - $643.92 $2,959 - $3,863
6 Added 10.91%
61 $38,000
Q1 2020

May 13, 2020

SELL
$336.18 - $494.43 $3,361 - $4,944
-10 Reduced 15.38%
55 $27,000
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $17,818 - $24,473
65 New
65 $24,000
Q3 2019

Nov 13, 2019

SELL
$273.46 - $318.39 $20,509 - $23,879
-75 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$299.6 - $414.82 $28,162 - $38,993
-94 Reduced 55.62%
75 $23,000
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $35,719 - $42,198
96 Added 131.51%
169 $69,000
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $24,514 - $29,421
73 New
73 $27,000
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $0 - $0
0 New
0 $0

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.